Literature DB >> 30680771

Hepatitis B variants among Egyptian patients undergoing hemodialysis.

Nashwa H M Abdel-Maksoud1, Ahmed El-Shamy2, Mohamed Fawzy3, Hanaa H A Gomaa1, Mokhtar M A Eltarabilli3.   

Abstract

Hepatitis B virus (HBV) infection is a serious nosocomial infection that affects patients undergoing hemodialysis (HD). However, certain HBV variants are not detected by routine serological tests in Egyptian dialysis units because of mutations that change important viral antigens (Ags). Of note, these mutations can result in the appearance of different HBV variants with different clinical manifestations. Thus, the present study aimed to assess different clinical forms of HBV infections and viral genotypes among patients undergoing HD in the Ismailia governorate of Egypt. To this end, serum samples were collected from 150 patients undergoing HD and screened for HBV-DNA using a nested PCR technique. Positive samples were then screened for HBV serological markers (hepatitis B core antibody [HBcAb], hepatitis B surface antigen, hepatitis B surface antibody, hepatitis B e antigen and hepatitis B e antibody) using ELISA and the HBV viral load quantitated by qPCR. HBV genotypes were detected by direct sequencing of the partial surface (S) gene. The most common clinical form of HBV infection in our study cohort was overt HBV infection (10%); followed by seropositive occult hepatitis B infection (7.3%), most of whom had an isolated HBcAb. The least common form was the precore mutant (1.3%). All HBV isolates were genotype D. This study reveals the importance of HBcAb and PCR in screening for HBV, especially for detection of occult hepatitis B infection.
© 2019 The Societies and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  hemodialysis; occult hepatitis B; precore mutant

Mesh:

Substances:

Year:  2019        PMID: 30680771     DOI: 10.1111/1348-0421.12670

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  3 in total

1.  The Guerilla Tactics of Hepatitis B Virus in Hemodialysis: Fighting a Stubborn Foe.

Authors:  Leslie P Wong
Journal:  Kidney Med       Date:  2019-10-30

2.  Mutations in Animal SARS-CoV-2 Induce Mismatches with the Diagnostic PCR Assays.

Authors:  Ahmed Elaswad; Mohamed Fawzy
Journal:  Pathogens       Date:  2021-03-19

3.  The prevalence and associated factors of hepatitis B and C virus in hemodialysis patients in Africa: A systematic review and meta-analysis.

Authors:  Tiruneh Adane; Solomon Getawa
Journal:  PLoS One       Date:  2021-06-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.